Overview
Portfolio
More
Newrhein
Philadelphia, United States
Private equity‑style venture capital investing in later‑stage, de‑risked life‑science assets with proven clinical safety and efficacy, focusing on cost‑effective, repurposed products that deliver health benefits and econ...
Portfolio
7+
Employees
15+
Founded
2010
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Newrhein
Private equity‑style venture capital investing in later‑stage, de‑risked life‑science assets with proven clinical safety and efficacy, focusing on cost‑effective, repurposed products that deliver health benefits and economic value.
Portfolio
7+
Employees
15+
Founded
2010
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 7 of 7 matched portfolio companies
The startup develops sterile injectable drug products, including prefilled syringes and vials, to address the issue of drug shortages in healthcare settings. By minimizing the resources required for medication preparation and administration, the company enhances operational efficiency for hospitals, outpatient centers, and clinics.
Butterfly Medical has developed a minimally invasive, implantable device that treats Benign Prostatic Hyperplasia (BPH) by retracting lateral lobes without cutting or burning tissue. This non-surgical solution offers a reversible treatment option for the approximately 30 million men worldwide experiencing BPH symptoms, significantly improving their quality of life.
Corsair Pharma is developing a transdermal patch that delivers an inactive prodrug of treprostinil to provide consistent blood levels for patients with pulmonary arterial hypertension (PAH). This approach eliminates the need for invasive intravenous or subcutaneous administration, reducing pain and improving treatment adherence.
Funding: $23.0M
Rough estimate of the amount of funding raised
Funding: $23.0M
Rough estimate of the amount of funding raised
E INC enhances the automotive purchasing process by providing a digital platform that streamlines wholesale and retail transactions through advanced technology and data analytics. This approach addresses inefficiencies in the automotive ecosystem, enabling faster and more flexible business operations for dealers and consumers.
HARM provides an AI-powered platform for individuals experiencing harm to quickly access immediate, trusted support. The system intelligently identifies the nature of the reported harm and routes users directly to appropriate, city-approved advocacy, legal, or housing resources. This streamlined process eliminates confusion while generating de-identified data insights to help municipal leaders optimize community support services.
RA UNLIMITED harnesses solar photovoltaic technology to generate clean and affordable electricity for homes, businesses, and communities in the Philippines. The company addresses the reliance on fossil fuels by providing sustainable energy solutions that create jobs and enhance the quality of life for Filipinos.
Theranica develops prescription digital therapeutics that utilize remote electrical neuromodulation to trigger conditioned pain modulation, effectively reducing migraine pain without medication. Their wearable device, Nerivio, stimulates peripheral nerves to enhance the brain's natural pain inhibition mechanisms, providing a safe and drug-free alternative for pain management.